EPISODE · Feb 8, 2026 · 20 MIN
Highlights of 2025 in low- and intermediate-risk prostate cancer
from EAU Podcasts · host European Association of Urology
In this episode, UROONCO PCa associate editor Prof. Claudia Kesch (DE) interviews Dr. Jochen Walz (FR) about the key highlights of 2025 in low- to intermediate-risk prostate cancer.They discuss advances in imaging diagnostics, artificial intelligence and biomarkers, active surveillance, surgical techniques and radiotherapy, as well as what is anticipated in 2026. Here are the links to the articles and interviews on the trials which were mentioned in this podcast: OPTIMUM TrialPRIME TrialBARCODE1 studyNeuroSAFE PROOF trial resultsENZARAD trial For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Embed this episode
What this episode covers
In this episode, UROONCO PCa associate editor Prof. Claudia Kesch (DE) interviews Dr. Jochen Walz (FR) about the key highlights of 2025 in low- to intermediate-risk prostate cancer. They discuss advances in imaging diagnostics, artificial intelligence and biomarkers, active surveillance, surgical techniques and radiotherapy, as well as what is anticipated in 2026. Here are the links to the articles and interviews on the trials which were mentioned in this podcast: OPTIMUM TrialPRI...
NOW PLAYING
Highlights of 2025 in low- and intermediate-risk prostate cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.